Skip to main content
Erschienen in: Journal of Cancer Research and Clinical Oncology 4/2016

01.04.2016 | Original Article – Cancer Research

Cancer is associated with intraoperative and postprocedural complications and disorders

verfasst von: Louis Jacob, Karel Kostev

Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To analyze the impact of cancer on intraoperative and postprocedural complications (IPCs) in Germany.

Methods

Patients with first diagnosis of IPCs between 2010 and 2015 were identified in 982 general practitioners in the IMS Disease Analyzer database. Controls were included after individual matching (1:1) to IPC cases by age, gender, type of health insurance (private or statutory) and the physician. Demographic data included: age, sex and health insurance type (private or statutory). Clinical data included: cancer, diabetes, coronary heart disease including myocardial infarction, stroke including TIA, heart failure, chronic respiratory diseases, fractures and depression. A multivariate logistic model was used to calculate the risk of IPC on the basis of patient characteristics.

Results

A total of 5817 IPC patients and 5817 controls were included in this study. The mean age was 63.9 years, the proportion of people with private health insurance coverage was equal to 3.0 %, and the proportion of men was equal to 36.0 % in both groups; 21.5 % of IPC patients and 5.8 % of controls had cancer (p value <0.0001). Moreover, diabetes, coronary heart disease, stroke, heart failure, chronic respiratory disease, fractures and depression were also significantly more common in IPC patients than in controls. Cancer had a negative impact on the risk of IPC (OR 4.27, 95 % CI 3.76–4.85 and p value <0.0001). Coronary heart diseases, depression, fractures and chronic respiratory diseases were also significantly associated with an increased risk of IPC.

Conclusion

The present study indicates that cancer increases the risk of IPCs and may reduce the clinical benefits of surgery.
Literatur
Zurück zum Zitat Aoyama T, Murakawa M, Katayama Y, Yamaoku K, Kanazawa A, Higuchi A, Shiozawa M, Morimoto M, Yoshikawa T, Yamamoto N et al (2015) Impact of postoperative complications on survival and recurrence in pancreatic cancer. Anticancer Res 35:2401–2409PubMed Aoyama T, Murakawa M, Katayama Y, Yamaoku K, Kanazawa A, Higuchi A, Shiozawa M, Morimoto M, Yoshikawa T, Yamamoto N et al (2015) Impact of postoperative complications on survival and recurrence in pancreatic cancer. Anticancer Res 35:2401–2409PubMed
Zurück zum Zitat Becher H, Kostev K, Schröder-Bernhardi D (2009) Validity and representativeness of the “disease analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 47:617–626CrossRefPubMed Becher H, Kostev K, Schröder-Bernhardi D (2009) Validity and representativeness of the “disease analyzer” patient database for use in pharmacoepidemiological and pharmacoeconomic studies. Int J Clin Pharmacol Ther 47:617–626CrossRefPubMed
Zurück zum Zitat Chok KS, Ng KK, Poon RT, Lo CM, Fan ST (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96:81–87. doi:10.1002/bjs.6358 CrossRefPubMed Chok KS, Ng KK, Poon RT, Lo CM, Fan ST (2009) Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg 96:81–87. doi:10.​1002/​bjs.​6358 CrossRefPubMed
Zurück zum Zitat Goldman L, Caldera DL, Southwick FS, Nussbaum SR, Murray B, O’Malley TA, Goroll AH, Caplan CH, Nolan J, Burke DS et al (1978) Cardiac risk factors and complications in non-cardiac surgery. Medicine (Baltimore) 57:357–370CrossRef Goldman L, Caldera DL, Southwick FS, Nussbaum SR, Murray B, O’Malley TA, Goroll AH, Caplan CH, Nolan J, Burke DS et al (1978) Cardiac risk factors and complications in non-cardiac surgery. Medicine (Baltimore) 57:357–370CrossRef
Zurück zum Zitat Jakobson T, Karjagin J, Vipp L, Padar M, Parik A-H, Starkopf L, Kern H, Tammik O, Starkopf J (2014) Postoperative complications and mortality after major gastrointestinal surgery. Medicina (Mexico) 50:111–117. doi:10.1016/j.medici.2014.06.002 CrossRef Jakobson T, Karjagin J, Vipp L, Padar M, Parik A-H, Starkopf L, Kern H, Tammik O, Starkopf J (2014) Postoperative complications and mortality after major gastrointestinal surgery. Medicina (Mexico) 50:111–117. doi:10.​1016/​j.​medici.​2014.​06.​002 CrossRef
Zurück zum Zitat Schoenfeld AJ, Ochoa LM, Bader JO, Belmont PJ (2011) Risk factors for immediate postoperative complications and mortality following spine surgery: a study of 3475 patients from the National Surgical Quality Improvement Program. J Bone Joint Surg Am 93(17):1577–1582. doi:10.2106/JBJS.J.01048 CrossRefPubMed Schoenfeld AJ, Ochoa LM, Bader JO, Belmont PJ (2011) Risk factors for immediate postoperative complications and mortality following spine surgery: a study of 3475 patients from the National Surgical Quality Improvement Program. J Bone Joint Surg Am 93(17):1577–1582. doi:10.​2106/​JBJS.​J.​01048 CrossRefPubMed
Zurück zum Zitat Virkkunen J, Heikkinen M, Lepäntalo M, Metsänoja R, Salenius J-P (2004) Finnvasc Study Group: diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. J Vasc Surg 40:761–767. doi:10.1016/j.jvs.2004.07.040 CrossRefPubMed Virkkunen J, Heikkinen M, Lepäntalo M, Metsänoja R, Salenius J-P (2004) Finnvasc Study Group: diabetes as an independent risk factor for early postoperative complications in critical limb ischemia. J Vasc Surg 40:761–767. doi:10.​1016/​j.​jvs.​2004.​07.​040 CrossRefPubMed
Zurück zum Zitat Vonlanthen R, Slankamenac K, Breitenstein S, Puhan MA, Muller MK, Hahnloser D, Hauri D, Graf R, Clavien P-A (2011) The impact of complications on costs of major surgical procedures: a cost analysis of 1200 patients. Ann Surg 254:907–913. doi:10.1097/SLA.0b013e31821d4a43 CrossRefPubMed Vonlanthen R, Slankamenac K, Breitenstein S, Puhan MA, Muller MK, Hahnloser D, Hauri D, Graf R, Clavien P-A (2011) The impact of complications on costs of major surgical procedures: a cost analysis of 1200 patients. Ann Surg 254:907–913. doi:10.​1097/​SLA.​0b013e31821d4a43​ CrossRefPubMed
Zurück zum Zitat Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA (2008) An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet Lond Engl 372:139–144. doi:10.1016/S0140-6736(08)60878-8 CrossRef Weiser TG, Regenbogen SE, Thompson KD, Haynes AB, Lipsitz SR, Berry WR, Gawande AA (2008) An estimation of the global volume of surgery: a modelling strategy based on available data. Lancet Lond Engl 372:139–144. doi:10.​1016/​S0140-6736(08)60878-8 CrossRef
Metadaten
Titel
Cancer is associated with intraoperative and postprocedural complications and disorders
verfasst von
Louis Jacob
Karel Kostev
Publikationsdatum
01.04.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Cancer Research and Clinical Oncology / Ausgabe 4/2016
Print ISSN: 0171-5216
Elektronische ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-015-2091-2

Weitere Artikel der Ausgabe 4/2016

Journal of Cancer Research and Clinical Oncology 4/2016 Zur Ausgabe

Review – Cancer Research

PLCε signaling in cancer

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.